Cargando…

The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis

BACKGROUND: Venous thromboembolism (VTE) in ovarian cancer (OC) patients has been widely investigated, but our knowledge on the role of VTE in OC patients receiving chemotherapy is limited. The aim of our study was to investigate the prevalence, risk factors, and prognostic value of chemotherapy-ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Lu, Cai, Li, Fu, Yonghui, Zhuang, Debao, Hu, Xiaoqing, Jie, Youkun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807708/ https://www.ncbi.nlm.nih.gov/pubmed/33441137 http://dx.doi.org/10.1186/s12957-020-02101-5

Ejemplares similares

MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
por: Cai, Li, et al.
Publicado: (2021)

The risk of venous thromboembolism in cancer patients receiving chemotherapy: a meta-analysis with systematic review
por: Bao, Yun, et al.
Publicado: (2021)

Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer
por: Chavan, Devendra Manik, et al.
Publicado: (2017)

ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer
por: Jie, Youkun, et al.
Publicado: (2020)

Characteristic and Prognostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study
por: Ye, Shuang, et al.
Publicado: (2015)

Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study
por: Kitayama, Hiromitsu, et al.
Publicado: (2017)

Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Blanco-Molina, Angeles, et al.
Publicado: (2014)

Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care
por: Allende-Pérez, Silvia Rosa, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of Immune/Inflammation Biomarkers for Venous Thromboembolism: Is It Reliable for Clinical Practice?
por: Xue, Junshuai, et al.
Publicado: (2021)

Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19
por: Paz Rios, Luis H., et al.
Publicado: (2021)

Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer
por: Cai, Li, et al.
Publicado: (2022)

Effect of ovarian tumor characteristics on venous thromboembolic risk
por: Bakhru, Arvind
Publicado: (2013)

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer
por: Glassman, Deanna, et al.
Publicado: (2022)

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients
por: Takeshima, Masahiro, et al.
Publicado: (2020)

Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study
por: Nordstrom, Beth L., et al.
Publicado: (2022)

Uncertainties on the prognostic value of admission D‐dimer on venous thromboembolism occurrence in patients with COVID‐19
por: Zhang, Litao, et al.
Publicado: (2022)

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis
por: Huang, Jimmy, et al.
Publicado: (2022)

Characteristics and Prognostic Factors of Venous Thromboembolism in Cancer Patients
por: Tsuyuki, Hajime, et al.
Publicado: (2022)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Prevalence and treatment of venous thromboembolism in patients with solid tumors
por: Zhao, Huihan, et al.
Publicado: (2022)

Prevalence of Venous Thromboembolism in Critically Ill Patients With Coronavirus Disease 2019: A Meta-Analysis
por: Wu, Changgang, et al.
Publicado: (2021)

Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study
por: Notten, Pascale, et al.
Publicado: (2020)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
por: Zheng, Chen, et al.
Publicado: (2023)

Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
por: Xu, Yaqian, et al.
Publicado: (2020)

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020)

Incidence of venous thromboembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective study
por: Park, Kwonoh, et al.
Publicado: (2017)

Simple yet (more?) effective. Venous thromboembolism risk assessment model for germ cell tumour patients receiving first‐line chemotherapy
por: Michalski, Wojciech, et al.
Publicado: (2023)

High incidence of silent venous thromboembolism before treatment in ovarian cancer
por: Satoh, T, et al.
Publicado: (2007)

Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis
por: Lee, Mei-Chuan, et al.
Publicado: (2022)

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
por: Cao, Maria D, et al.
Publicado: (2012)

Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors
por: Cook, Deborah, et al.
Publicado: (2008)

Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
por: Wang, Yuhan, et al.
Publicado: (2022)

The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis
por: Zhang, Chuanlin, et al.
Publicado: (2019)

Prevalence and associated factors of developing venous thromboembolism in the perioperative period
por: Okada, K, et al.
Publicado: (2015)

Patient Preferences for Receiving Education on Venous Thromboembolism Prevention – A Survey of Stakeholder Organizations
por: Popoola, Victor O., et al.
Publicado: (2016)

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
por: Cornell, Robert Frank, et al.
Publicado: (2019)

Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network
por: Ruigómez, Ana, et al.
Publicado: (2020)

Thalassemia and Venous Thromboembolism
por: Succar, Julien, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_j53tqhva11oomuh5i1dl3ve14a